跳至主要内容
临床试验/IRCT201109207602N1
IRCT201109207602N1已完成3 期

Evaluation of the effectiveness of a new herbal formulation for improving blood sugar control in patients with type 2 diabetes mellitus.

Iran's National Elites Foundation (INEF)0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 65 years(—)
性别
All

入选标准

  • newly diagnosed diabetes according to ADA 2014 (FPG=>126 mg/dl or HgA1C=>6.4% or BS=>200 mg/dl after OGTT or random BS =>200 and hyperglycemic symptoms); age 30-65 years; signed consent form.
  • Exclusion criteria: Diabetes type 1; insulin injection during 8 weeks ago; serious infectious diseases; renal failure (GFR< 50 cc/min/); liver failure ( high ALTor/and AST more than 3 times above normal range); cardiac failure; pregnancy and/or breast feeding; past history of seizure or epilepsy.

排除标准

  • 未提供

研究者

发起方
Iran's National Elites Foundation (INEF)

相似试验

The effect of herbal supplement in type 2 diabetes... | 临床试验